granulocyte macrophage colony-stimulating factor

Tanner Pharma Group Expands Ex-US Access Program to Provide LEUKINE® for Use in Patients with Respiratory Illness Associated with COVID-19

Charlotte, N.C., United States:  Topline clinical trial results showed LEUKINE® was safe, well tolerated and generated T cells targeted at…

Read More »